1140 related articles for article (PubMed ID: 15956814)
21. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
Kim CY; Lee C; Park GH; Jang JH
Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.
Xu Q; Langley M; Kanthasamy AG; Reddy MB
J Nutr; 2017 Oct; 147(10):1926-1931. PubMed ID: 28835392
[No Abstract] [Full Text] [Related]
24. Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.
Chen SQ; Wang ZS; Ma YX; Zhang W; Lu JL; Liang YR; Zheng XQ
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495349
[TBL] [Abstract][Full Text] [Related]
25. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
26. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
Azam S; Hadi N; Khan NU; Hadi SM
Toxicol In Vitro; 2004 Oct; 18(5):555-61. PubMed ID: 15251172
[TBL] [Abstract][Full Text] [Related]
27. Advances in metal-induced oxidative stress and human disease.
Jomova K; Valko M
Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
[TBL] [Abstract][Full Text] [Related]
28. Potential role of green tea catechins in various disease therapies: progress and promise.
Mak JC
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):265-73. PubMed ID: 22229384
[TBL] [Abstract][Full Text] [Related]
29. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
30. Medicinal benefits of green tea: Part I. Review of noncancer health benefits.
Cooper R; Morré DJ; Morré DM
J Altern Complement Med; 2005 Jun; 11(3):521-8. PubMed ID: 15992239
[TBL] [Abstract][Full Text] [Related]
31. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
32. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
34. The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Arch Biochem Biophys; 2008 Aug; 476(2):152-60. PubMed ID: 18211800
[TBL] [Abstract][Full Text] [Related]
35. Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
Jayasena T; Grant RS; Keerthisinghe N; Solaja I; Smythe GA
Neurosci Res; 2007 Mar; 57(3):454-61. PubMed ID: 17210195
[TBL] [Abstract][Full Text] [Related]
36. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
[TBL] [Abstract][Full Text] [Related]
37. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
Zaveri NT
Life Sci; 2006 Mar; 78(18):2073-80. PubMed ID: 16445946
[TBL] [Abstract][Full Text] [Related]
38. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects.
Yamamoto T; Lewis J; Wataha J; Dickinson D; Singh B; Bollag WB; Ueta E; Osaki T; Athar M; Schuster G; Hsu S
J Pharmacol Exp Ther; 2004 Jan; 308(1):317-23. PubMed ID: 14569057
[TBL] [Abstract][Full Text] [Related]
39. Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits.
Afzal O; Dalhat MH; Altamimi ASA; Rasool R; Alzarea SI; Almalki WH; Murtaza BN; Iftikhar S; Nadeem S; Nadeem MS; Kazmi I
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364431
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting the levels of tea polyphenols and caffeine in tea leaves.
Lin YS; Tsai YJ; Tsay JS; Lin JK
J Agric Food Chem; 2003 Mar; 51(7):1864-73. PubMed ID: 12643643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]